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ABSTRACT
Objective: The main objective of review is an effort to give detailed information on Valeriana jatamansi and its multiple medicinal properties.
Methods: As per the literature, the plant V. jatamansi is a perennial herb and found at subtemperate Himalayan regions of the Kumaon and Garhwal. 
The plant most popularly known as “Valerian.” The plant belongs to the family Valerianaceae. The roots and rhizomes of the plants are traditionally 
used to treat ulcers, jaundice, dry cough, seminal weakness, skin diseases, leprosy, and for sleep enhancement due to the presence of a variety of 
different chemical constituents such as sesquiterpenes, coumarins, iridoids, lignanoids, alkaloids, and flavonoids. From literature, the reported 
methods performed for different pharmacological activities have been thoroughly discussed and complied.
Results: Most of the studies compiled from literature shown that V. jatamansi possess antimicrobial, antioxidant, anti-inflammatory, cytotoxic, 
anxiolytic, and neuroprotective activities.
Conclusion: The review reveals that continuous research on this plant is needed to know the exact molecular mechanism and further elaborative 
studies can lead to develop safe therapeutic use in modern medicine.
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INTRODUCTION
The genus Valeriana belonging to the family Valerianaceae contains 
around 250 types of species which is distributed in all temperate 
regions of world. Among them in India, 16 species were found and out 
of them two subspecies of genus and five species in habitat at higher 
altitude range of Central Himalayas. The most popular name for this 
genus is “Valeriana.” Valeriana jatamansi is commonly known as India 
Valerian, Muskbala, Sugandhbala (Hindi), and Tagar (Sanskrit) [1]. 
Indian Valeriana is a small herbaceous species distributed in tropical 
and temperate Himalaya up to an altitude of 3000 m between 1500 and 
1800 m in Khasi and Jaintia hills; this has been used as an ingredient 
for herbal medicine in Indian system of medicine and substitutes for 
European Valeriana officinalis in India. Geographically, this species 
is available in different temperate regions and has diverse genetic 
and morphological features, which will affect the level of active 
constituents present [2]. V. jatamansi is a hairy dwarf and rhizomatous 
perennial herb growing up to 0.5 m with thick root stacks, covered with 
horizontal descending fibers and pubescent stem and radical leaves 
1–3 cm in diameter. Flowers are white or tinged in pink color, fruits 
are crowned by persistent pappus calyx. This species is gynodioecious, 
the fruiting and flowering time occurs during the period of March–June 
and mode of proliferation is both sexual through seeds and abiogenetic 
through rhizome. V. jatamansi used in Ayurvedic and Unani system of 
medicine. The roots and rhizomes are used to treat insomnia, blood and 
circulatory disorders, asthma, dry cough, jaundice, seminal weakness, 
cardiac debility, and skin diseases. Its herbal oil is widely in use for 
making perfumery preparation and in insect repellent formulation. 
The V. jatamansi root contains 0.8% of essential oil and used in 








Botanical name: V. jatamansi
Synonyms




Hindi Balchhari, Mansi, Nihani, Smak, Sumaya, Tagar
Kannada Jatale, Naati jatamaansi, Nandu batlu, Tagara
Malayalam Takaram
Marathi Thagar mool
Sanskrit Jatamansi, Natah, Tagarah
Tamil Shadamangie, Takaram
Telugu Tagara
Macroscopical characters of dried rhizome
Dried rhizome is prolonged cylindrical in shape 2.5–12 cm long and 
2–3.5 cm thick covered by groups of thick brownish rootlets bundles 









V. jatamansi main active constituents are sesquiterpenes, coumarins, 
iridoids, liganoids, and sesquiterpenes include valerenic acid, and 
other derivatives include valeranone and valerenal. Moreover, liganoids 
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include pinoresinol-4-o-d-glucoside and lignans 8’-hydro-xypinoresinol. 
Iridoids include valepotriates (valtrate, didrovaltrate, acevaltrate, 
and isovaleroxyhydroxyvaltrate) [6,7]. Alkaloids include chatinine, 
nordelporphine, norphoebine, thaliperphine, nantenine, phenanthrene, 
phoebine, dehydroaphine, valerine, valeriane, and oxoaporphine. 
Flavonoids in Valeriana mainly contain acacetin, hesperidin and 
methylapigenin, diosmetin, luteolin, quercetin, kaempferol, linarin, 
and luteolin. The other constituents are volatile oil, essential oil, sugar, 
bitter extractive matter, starch, gum, resin, and ketones [8,9].
Traditional uses
In traditional system of medicine, the roots of plant are used to treat 
ulcer, convulsion, asthma, dry cough, jaundice, seminal weakness, 
cardiac debility and skin diseases, leprosy, general debility, and for 
sleep enhancement. Rhizomes and roots of V. jatamansi recommended 
to treat insomnia and blood, circulatory, and mental disorders. It 
stimulates central nervous system, acts as nerve tonic, and used in the 
treatment of anxiety and tremors. The plant was used as stimulant, 
hypotensive, and sedative. Its oil is used in perfumery preparation and 
insect repellent formulation [10].
In vitro and in vivo studies
Antioxidant activity
Methanolic, chloroform, and aqueous extracts of the dried roots of 
V. jatamansi were extracted and assessed for their polyphenol and 
flavonoid content. The antioxidant activity of the three solvent extracts 
of V. jatamansi roots and essential oil (100 µg/ml) and was assessed by 
2,2-diphenyl-1-picrylhydrazylhydrate (DPPH) radical scavenging and 
ferrous chelation power assay [11]. Methanolic extract was found to 
be best when compared to that of essential oil [12]. In another study, 
the antioxidant activity and anti-inflammatory activity were studied 
by hydroalcoholic extracts of V. jatamansi using DPPH free radical 
scavenging and the percentage (%) inhibition of proteins denaturation, 
respectively, using diclofenac sodium as the reference standard. 
A substantial decrease of various mediators of inflammation was seen 
due to the presence of bioactive compounds such as flavonoids, tannins, 
and polyphenols [13].
Anti-inflammatory activity
The aqueous and methanolic extracts from the rhizomes of V. jatamansi 
had shown to have significant anti-inflammatory activity. It decreases 
the inflammation in carrageenan-induced paw edema method in rats 
at dose levels of 100, 150, and 200 mg/kg in the presence of saline as 
control and reference drug was aspirin. Both the extracts significantly 
decreased due to inhibition of inflammatory mediators histamine, 
prostaglandin, and serotonin synthesis and exhibited anti-inflammatory 
effect at 200 mg/kg dose [14].
Antibacterial activity
The antibacterial activity was explored using hexane, chloroform, 
and methanolic extracts from rhizomes of V. jatamansi. Extended-
spectrum B-lactamase produced by Escherichia coli, Enterobacter 
aerogenes, Klebsiella pneumoniae, and Hafnia alvei were isolated from 
urinary tract infection and subjected to double disc diffusion assay 
using three solvent extracts [15]. The inhibition was significant with 
hexane extract and can be given along with other antibiotics as new 
alternative treatment for urinary tract infection [16]. The methanolic, 
chloroform, and hexane extracts of V. jatamansi were evaluated for 
their antimicrobial effect against strains Staphylococcus aureus, 
Pseudomonas aeruginosa, Micrococcus luteus, E. coli, Salmonella 
ebony, Lactobacillus plantarum, and Staphylococcus epidermidis. 
Among them, the hydroalcoholic extracts with doses of 0.3–0.7 mg/ml 
shown better antibacterial activity against S. aureus, P. aeruginosa 
by cup plate method using Soyabean Casein Digest Agar medium, 
and chloramphenicol was standard antibiotic used at 1 mg/ml. The 
antibacterial activity was due to the presence of valerenic acid an 
important chemical constituent which was isolated and characterized 
by thin-layer chromatography (TLC) and high-performance liquid 
chromatography (HPLC) by comparing the Rf and Rt values using 
reference standard compound can be a better choice as a new 
antibacterial agent [17].
Cytotoxic activity
The underground parts, roots and rhizomes of all three Valeriana 
species V. jatamansi (V. wallichii), V. officinalis, and V. edulis Nutt, 
possess cytotoxic activity which has been proven by different studies. 
Fresh extracts and stored extract tinctures of three valerian species 
were explored for active principles baldrinals, valepotriates, and 
valerenic acid and cytotoxic activity was performed against COLO 320 a 
human colorectal and GLC (4) a human small cell lung cancer lines, by 
utilizing the microculture tetrazolium (MTT) assay [18]. A significant 
highest toxicity was observed by diene-type valepotriates (isovaltrate, 
acevaltrate, and valtrate) with IC50 (1–6 µM), following continuous 
incubation. The data imply that isovaltral obtained from isovaltrate 
possess marked effects than its parent compound. The cytotoxic effect 
got reduced on storage as valepotriates decomposed, which shown 
weak cytotoxic effect [19].
An in vitro cytotoxic study was conducted on three valepotriate isomers, 
jataman valtrates Z1, Z2, and Z3, obtained from the air-dried whole plants 
of V. jatamansi (syn. V. wallichii). It was found that methanolic extracts 
exhibited moderate cytotoxicity using MTT assay against the metastatic 
prostate cancer (PC3M), lung adenocarcinoma (A549), hepatoma 
(Bel7402) cell lines, and colon cancer (HCT-8) [19]. The viability of cell 
lines was measured by observing absorbance at 570 nm using dimethyl 
sulfoxide as solvent and paclitaxel as positive control with IC50 values 
of 2.8–8.3 µM [20].
Earlier studies reported that 10 new valepotriates, jataman valtrates 
(1–10), and one already reported compound, nardostachin (11), 
were extracted and isolated from the entire plants of V. jatamansi. 10 
new valepotriates, jataman valtrates, compound’s structures were 
determined by spectroscopic analysis and were subjected to access 
cytotoxic action against PC-3M cell lines, and SAR studies were 
performed and tested for all the above compounds and the in vitro 
cytotoxic data report proposed some particular functional groups were 
related to the cytotoxic activity against PC-3M cell lines. An unsaturated 
bond at C3-C4, the oxirane ring, and at C-10 the chlorine atom presence in 
the valepotriates was highlighted as important structural features [21].
Anxiolytic activity
The anxiolytic properties of compound were explored from radix 
and rhizomes of Valeriana jatamansi in mice [22]. Male ICR mice 
were treated with compound V. jatamansi at dose levels of 1.2 g/kg, 
2.4 g/kg, and 4.8 g/kg and saline, diazepam 2 mg/kg given orally for 
10 days and then examined using techniques elevated maze-plus (EPM) 
and light-dark box (LDB) [23,24]. The compounds effect on mice was 
spontaneous and tested by locomotor activity test. At higher doses, the 
mice demonstrated more number of entries and additional time was 
spent on the open arms of EPM [25]. The transitions occurred have also 
increased, and similarly, more time was spent in light compartment of 
the LBD. Treatment with flumazenil significantly reduces anxiolytic-like 
effects, but treatment with V. jatamansi did not affect the spontaneous 
activity in mice. The study concludes that the compound V. jatamansi can 
be a better choice for anxiolytic action than producing sedation [26,27].
In another study, the anxiolytic activity was performed using iridoid 
fraction which was obtained from rhizomes and radix of V. jatamansi using 
D-101 resin. The major constituents were analyzed preliminarily by TLC, 
UV spectrophotometry, and HPLC, and its antianxiety effects at 6 mg/kg, 
9 mg/kg, and 12 mg/kg were evaluated using elevated plus maze technique, 
the Vogel’s drinking conflict technique, the open field drink technique, and 
the LDB technique. The mechanism of action was investigated using ELISA 
technique and it was shown by regulating GABA level [28].
Neuroprotective effect
Neuroprotective activity of methanolic extract of the dried roots of 
V. jatamansi was explored using three new iridoids, valeriandoids 
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A-C(1-3), and other three already reported compounds (4–6) were 
subjected against (MPP+) 1-methyl-4-phenylpyridinium-induced 
neuronal apoptosis in the neuroblastoma of dopaminergic SH-SY5Y 
utilizing guanosine as positive control. Among these six compounds, 
four had showed moderate neuroprotective effect (Fig. 1) [8,29].
CONCLUSION
V. jatamansi is a perennial herb grown in higher altitude regions of 
Himalayas is an important ayurvedic plant with multiple remedies. The 
roots and rhizomes of the plant had substantial number of chemical 
constituents such as iridoids, liganoids, valeriandoids, and valepotriates 
which are used to treat various ailments. Pharmacologically, it has 
been evaluated for in vitro antimicrobial, antioxidant, and anticancer 
activity and in vivo anti-inflammatory, anxiolytic, and neuroprotective 
activity [30]. However, continuous research on this plant is needed to 
know the exact molecular mechanism, and further, elaborative studies 
can lead to develop safe therapeutic use in modern medicine.
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Fig. 1: Morphology of Valeriana Jatamansi, (a) whole plant, 
(b) flower at early stage [5]
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